NRAS and cancer: In this case series, as these molecular tests mentioned above are not yet available in China and are expensive, the department of pathology detected the most common cancer-associated somatic mutations (BRAF, HRAS, NRAS, KRAS, and TERT) in 115 of 265 specimens from ITNs.